Nanomedicine gets personal

Science Translational Medicine

Volumn 7, Issue 314, 2015, Pages

  Tietjen, Gregory T ^a   Saltzman, W Mark ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROGOL; NANOPARTICLE; POLYGLACTIN;

ANTIBODY SPECIFICITY; ARTICLE; BLOOD BRAIN BARRIER; CANCER STAGING; GENE EXPRESSION PROFILING; GENETIC VARIABILITY; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HUMAN; NANOMEDICINE; NON SMALL CELL LUNG CANCER; PERSONALIZED MEDICINE; PRIORITY JOURNAL; TUMOR VASCULARIZATION; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM;

DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; HUMANS; NANOMEDICINE; NANOPARTICLES;

EID: 84947787411     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aad6645     Document Type: Article

References (10)

1. M. A. Miller, S. Gadde, C. Pf rschke, C. Engblom, M. M. Sprachman, R. H. Kohler, K. S. Yang, A. M. Laughney, G. Wojtkiewicz, N. Kamaly, S. Bhonagiri, M. J. Pittet, O. C. Farokhzad, R. Weissleder, Predicting therapeutic nanomedicine ef cacy using a companion magnetic resonance imaging nanoparticle. Sci. Transl. Med. 7, 314ra183 (2015).
2. Y. Matsumura, H. Maeda, A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46, 6387-6392 (1986).
3. J. Kreuter, Drug delivery to the central nervous system by polymeric nanoparticles: What do we know? Adv. Drug Deliv. Rev. 71, 2-14 (2014).
4. M. C. Ferrier, H. Sarin, S. H. Fung, B. Schatlo, R. M. Pluta, S. N. Gupta, P. L. Choyke, E. H. Oldf eld, D. Thomasson, J. A. Butman, Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model. Neoplasia 9, 546-555 (2007).
5. J. H. Ryu, S. Lee, S. Son, S. H. Kim, J. F. Leary, K. Choi, I. C. Kwon, Theranostic nanoparticles for future personalized medicine. J. Control. Release 190, 477-484 (2014).
6. R. S. Bindra, S. L. Wolden, Advances in radiation therapy in pediatric neuro-oncology. J. Child Neurol. (2015). 10.1177/0883073815597758
7. J. Hrkach, D. Von Hof, M. M. Ali, E. Andrianova, J. Auer, T. Campbell, D. De Witt, M. Figa, M. Figueiredo, A. Horhota, S. Low, K. McDonnell, E. Peeke, B. Retnarajan, A. Sabnis, E. Schnipper, J. J. Song, Y. H. Song, J. Summa, D. Tompsett, G. Troiano, T. Van Geen Hoven, J. Wright, P. LoRusso, P. W. Kantof, N. H. Bander, C. Sweeney, O. C. Farokhzad, R. Langer, S. Zale, Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a dif erentiated pharmacological prof le. Sci. Transl. Med. 4, 128ra39 (2012).
8. I. A. Babar, C. J. Cheng, C. J. Booth, X. Liang, J. B. Weidhaas, W. M. Saltzman, F. J. Slack, Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc. Natl. Acad. Sci. U.S.A. 109, E1695-E1704 (2012).
9. C. J. Cheng, G. T. Tietjen, J. K. Saucier-Sawyer, W. M. Saltzman, A holistic approach to targeting disease with polymeric nanoparticles. Nat. Rev. Drug Discov. 14, 239-247 (2015).
10. Z. Cheng, A. Al Zaki, J. Z. Hui, V. R. Muzykantov, A. Tsourkas, Multifunctional nanoparticles: Cost versus benef t of adding targeting and imaging capabilities. Science 338, 903-910 (2012).